1. Home
  2. CATX
  3. CATX News

Latest Perspective Therapeutics Inc. (CATX) News on November 17, 2024

Is Perspective Therapeutics (CATX) the Best Multibagger Stock to Buy Heading into 2025?
CATX

Insider Monkey

a day ago

Is Perspective Therapeutics (CATX) the Best Multibagger Stock to Buy Heading into 2025?

Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
CATX

GlobeNewswire

2 days ago

Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024

CATX

MT Newswires

4 days ago

RBC Trims Price Target on Perspective Therapeutics to $25 From $27, Keeps Outperform, Speculative Risk

CATX

Associated Press Finance

5 days ago

Perspective Therapeutics: Q3 Earnings Snapshot

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results
CATX

GlobeNewswire

5 days ago

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results

Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results
CATX

GlobeNewswire

17 days ago

Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results

Perspective Therapeutics to Participate in Upcoming Investor Conferences in November
CATX

GlobeNewswire

19 days ago

Perspective Therapeutics to Participate in Upcoming Investor Conferences in November

CATX

MT Newswires

24 days ago

UBS Initiates Perspective Therapeutics at Buy With $20 Price Target

Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine
CATX

GlobeNewswire

25 days ago

Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine

CATX

MT Newswires

a month ago

Perspective Therapeutics Makes First Shipment of Investigational Products From New Jersey Facility

Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey
CATX

GlobeNewswire

a month ago

Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey

Perspective Therapeutics, Inc (CATX): A Small-Cap Pioneer in Targeted Cancer Therapies
CATX

Insider Monkey

a month ago

Perspective Therapeutics, Inc (CATX): A Small-Cap Pioneer in Targeted Cancer Therapies

CATX

MT Newswires

a month ago

Wedbush Adjusts Price Target on Perspective Therapeutics to $20 From $25, Maintains Outperform Rating

CATX

MT Newswires

a month ago

Perspective Therapeutics Says Initial Data Show Potential Melanoma Therapy's Safety, Efficacy

Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma Research
CATX

GlobeNewswire

a month ago

Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma Research

Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma Research
CATX

GlobeNewswire

a month ago

Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma Research

Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day
CATX

GlobeNewswire

a month ago

Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day

CATX

MT Newswires

2 months ago

Wedbush Initiates Perspective Therapeutics at Outperform With $25 Price Target

Perspective Therapeutics to Present at the 37th Annual Congress of the European Association of Nuclear Medicine
CATX

GlobeNewswire

2 months ago

Perspective Therapeutics to Present at the 37th Annual Congress of the European Association of Nuclear Medicine

CATX

MT Newswires

2 months ago

Update: Truist Initiates Perspective Therapeutics at Buy With $21 Price Target

CATX

MT Newswires

2 months ago

Truist Initiates Perspective Therapeutics at Buy

Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024
CATX

GlobeNewswire

2 months ago

Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024

CATX

MT Newswires

2 months ago

Perspective Therapeutics Gets FDA Fast Track Label for VMT01 to Treat Melanoma; Shares Rise

Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma
CATX

GlobeNewswire

2 months ago

Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma

Perspective Therapeutics to Participate in Upcoming Investor Conferences in September
CATX

GlobeNewswire

3 months ago

Perspective Therapeutics to Participate in Upcoming Investor Conferences in September

CATX

MT Newswires

3 months ago

RBC Adjusts Perspective Therapeutics' PT to $27 From $29, Keeps Outperform Rating, Speculative Risk

Is Perspective Therapeutics, Inc. (CATX) Outperforming Other Medical Stocks This Year?
CATX

Zacks

3 months ago

Is Perspective Therapeutics, Inc. (CATX) Outperforming Other Medical Stocks This Year?

CATX

MT Newswires

3 months ago

Oppenheimer Adjusts Perspective Therapeutics Price Target to $17 From $19, Maintains Outperform Rating

CATX

Associated Press Finance

3 months ago

Perspective Therapeutics: Q2 Earnings Snapshot

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 2Q 2024 Results
CATX

GlobeNewswire

3 months ago

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 2Q 2024 Results

Perspective Therapeutics to Participate at Upcoming Investor Conferences in August
CATX

GlobeNewswire

4 months ago

Perspective Therapeutics to Participate at Upcoming Investor Conferences in August

CATX

MT Newswires

4 months ago

BofA Securities Starts Perspective Therapeutics With Buy Rating, $24 Price Target

Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results
CATX

GlobeNewswire

4 months ago

Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results

Wall Street Analysts Think Perspective Therapeutics (CATX) Could Surge 80.31%: Read This Before Placing a Bet
CATX

Zacks

4 months ago

Wall Street Analysts Think Perspective Therapeutics (CATX) Could Surge 80.31%: Read This Before Placing a Bet

CATX

MT Newswires

5 months ago

Sector Update: Health Care Stocks Softer Wednesday Afternoon

CATX

MT Newswires

5 months ago

Perspective Therapeutics to Join Russell 3000 Index on July 1

Perspective Therapeutics Announces Inclusion in the Russell 3000® Index
CATX

GlobeNewswire

5 months ago

Perspective Therapeutics Announces Inclusion in the Russell 3000® Index

CATX

MT Newswires

5 months ago

Perspective Therapeutics to Reverse Split Common Shares

Perspective Therapeutics Announces 1-for-10 Reverse Stock Split
CATX

GlobeNewswire

5 months ago

Perspective Therapeutics Announces 1-for-10 Reverse Stock Split

Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
CATX

GlobeNewswire

5 months ago

Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting

CATX

MT Newswires

6 months ago

Perspective Therapeutics Prices $80 Million Share, Warrant Offering

Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
CATX

GlobeNewswire

6 months ago

Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024
CATX

GlobeNewswire

6 months ago

Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024

CATX

MT Newswires

6 months ago

Perspective Therapeutics Swings to Loss in Q1, Revenue Rises

CATX

Associated Press Finance

6 months ago

Perspective Therapeutics: Q1 Earnings Snapshot

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
CATX

GlobeNewswire

6 months ago

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results

Perspective Therapeutics to Participate at Upcoming May Investor Conferences
CATX

GlobeNewswire

6 months ago

Perspective Therapeutics to Participate at Upcoming May Investor Conferences

CATX

GuruFocus.com

6 months ago

Lantheus Holdings Inc (LNTH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...

Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results
CATX

GlobeNewswire

7 months ago

Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results

Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs
CATX

GlobeNewswire

7 months ago

Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs

Perspective Therapeutics to Participate at Upcoming April Investor Conferences
CATX

GlobeNewswire

7 months ago

Perspective Therapeutics to Participate at Upcoming April Investor Conferences

Perspective Therapeutics Inc (CATX) Reports Fiscal Year 2023 Financial Results
CATX

GuruFocus.com

8 months ago

Perspective Therapeutics Inc (CATX) Reports Fiscal Year 2023 Financial Results

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results
CATX

GlobeNewswire

8 months ago

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results

Heard on the Street: Pharma Goes Radioactive as AstraZeneca Announces Fusion Deal
CATX

The Wall Street Journal

8 months ago

Heard on the Street: Pharma Goes Radioactive as AstraZeneca Announces Fusion Deal

Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma
CATX

GlobeNewswire

8 months ago

Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma

Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024
CATX

GlobeNewswire

8 months ago

Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024

Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility
CATX

GlobeNewswire

8 months ago

Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility

Perspective Therapeutics Announces $87.4 Million Private Placement
CATX

GlobeNewswire

8 months ago

Perspective Therapeutics Announces $87.4 Million Private Placement

Perspective Therapeutics to Participate at Upcoming Investor Conferences
CATX

GlobeNewswire

9 months ago

Perspective Therapeutics to Participate at Upcoming Investor Conferences

These Drug Companies Are Going Nuclear to Fight Cancer
CATX

The Wall Street Journal

9 months ago

These Drug Companies Are Going Nuclear to Fight Cancer

PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth
CATX

Zacks

9 months ago

PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth

Perspective Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
CATX

GlobeNewswire

9 months ago

Perspective Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Earnings Preview: Perspective Therapeutics (CATX) Q4 Earnings Expected to Decline
CATX

Zacks

9 months ago

Earnings Preview: Perspective Therapeutics (CATX) Q4 Earnings Expected to Decline

Perspective Therapeutics Introduces “Pre-Targeting” Theranostic Technology Platform
CATX

GlobeNewswire

10 months ago

Perspective Therapeutics Introduces “Pre-Targeting” Theranostic Technology Platform

Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?
CATX

Zacks

10 months ago

Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?

CATX

Associated Press Finance

10 months ago

Financial Institutions: Q4 Earnings Snapshot

CATX

GuruFocus.com

10 months ago

Financial Institutions Inc (FISI) Reports Mixed Results Amidst Challenging Interest Rate Environment

Financial Institutions, Inc. Announces Fourth Quarter and Full Year 2023 Results
CATX

GlobeNewswire

10 months ago

Financial Institutions, Inc. Announces Fourth Quarter and Full Year 2023 Results

There's More to Restaurants Brands International's $1 Billion Acquisition Than Meets the Eye
CATX

Motley Fool

10 months ago

There's More to Restaurants Brands International's $1 Billion Acquisition Than Meets the Eye

XAI Octagon Floating Rate & Alternative Income Term Trust Announces Shareholder Approval of Important Proposals
CATX

Business Wire

10 months ago

XAI Octagon Floating Rate & Alternative Income Term Trust Announces Shareholder Approval of Important Proposals

Perspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private Placement
CATX

GlobeNewswire

10 months ago

Perspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private Placement

Potbelly Launches Reimagined Potbelly Perks Loyalty Program
CATX

PR Newswire

10 months ago

Potbelly Launches Reimagined Potbelly Perks Loyalty Program

Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement
CATX

GlobeNewswire

10 months ago

Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement

Perspective Therapeutics Announces Proposed Public Offering
CATX

GlobeNewswire

10 months ago

Perspective Therapeutics Announces Proposed Public Offering

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01
CATX

GlobeNewswire

10 months ago

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

Loss-Making iHeartMedia, Inc. (NASDAQ:IHRT) Set To Breakeven
CATX

Simply Wall St.

10 months ago

Loss-Making iHeartMedia, Inc. (NASDAQ:IHRT) Set To Breakeven

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics
CATX

GlobeNewswire

10 months ago

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability
CATX

GlobeNewswire

10 months ago

Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability

DocGo Subsidiary Achieves ISO 9001:2015 Certification, Further Elevating its Commitment to Quality Management
CATX

Business Wire

10 months ago

DocGo Subsidiary Achieves ISO 9001:2015 Certification, Further Elevating its Commitment to Quality Management

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024
CATX

GlobeNewswire

10 months ago

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

First Bank Announces Fourth Quarter 2023 Earnings Conference Call
CATX

GlobeNewswire

10 months ago

First Bank Announces Fourth Quarter 2023 Earnings Conference Call

Wallbox Announces Upcoming Events for the Investor Community
CATX

Business Wire

10 months ago

Wallbox Announces Upcoming Events for the Investor Community

With 77% ownership, Priority Technology Holdings, Inc. (NASDAQ:PRTH) insiders have a lot at stake
CATX

Simply Wall St.

a year ago

With 77% ownership, Priority Technology Holdings, Inc. (NASDAQ:PRTH) insiders have a lot at stake

12 Most Profitable Pot Stocks Now
CATX

Insider Monkey

a year ago

12 Most Profitable Pot Stocks Now

Priority Announces Strategic Technology Partnership with Treasure Financial
CATX

Business Wire

a year ago

Priority Announces Strategic Technology Partnership with Treasure Financial

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CATX

Business Wire

a year ago

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update
CATX

Business Wire

a year ago

KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update

Gannett Joins LOT Network to Protect Digital Asset Products from Patent Litigation
CATX

Business Wire

a year ago

Gannett Joins LOT Network to Protect Digital Asset Products from Patent Litigation

Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients
CATX

GlobeNewswire

a year ago

Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients

Investing $4,000 in These 4 Top Stocks Might Make You Rich
CATX

Motley Fool

a year ago

Investing $4,000 in These 4 Top Stocks Might Make You Rich

Belpointe OZ Announces Third Quarter Net Asset Value Per Class A Unit of $103.50
CATX

GlobeNewswire

a year ago

Belpointe OZ Announces Third Quarter Net Asset Value Per Class A Unit of $103.50

Humacyte Third Quarter 2023 Financial Results and Business Update
CATX

GlobeNewswire

a year ago

Humacyte Third Quarter 2023 Financial Results and Business Update

Saba Capital Management, L.P. Increases Stake in ASA Gold And Precious Metals Ltd
CATX

GuruFocus.com

a year ago

Saba Capital Management, L.P. Increases Stake in ASA Gold And Precious Metals Ltd

Share on Social Networks: